"The BiVACOR news would be a welcome development for companies such as Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF), which, like BiVACOR, is committed to discovering, developing and delivering innovative solutions for significant challenges facing heart patients and their physicians."
Link to full article below -
FDA approval for BiVACOR's artificial heart study paves further paths for heart tech innovation (*.com.au)
"The BiVACOR news would be a welcome development for companies...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.05 |
Change
-0.140(2.70%) |
Mkt cap ! $78.29M | |||
| Open | High | Low | Value | Volume |
| $5.08 | $5.17 | $5.00 | $17.07K | 3.383K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $5.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.18 | 2446 | 1 |
View Market Depth
| Last trade - 15.59pm 30/07/2025 (20 minute delay) ? |
| AVR (ASX) Chart |